Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.

The research examines the connections between the presence of specific biological markers (metalloproteinases and tumor necrosis factor-alpha) in horse’s synovial fluids and the severity of cartilage alterations, which are indicative of osteoarthritis. The study implies that metalloproteinases could be a potential marker for diagnosing early stages of osteoarthritis in horses, however, the activity of tumor necrosis factor-alpha did not show a similar correlation.

Research Methodology

• The synovial fluid was collected from 14 horses comprising 90 joints, before the horses were subjected to euthanasia.
• Post collection, the joints were observed with macroscopic examination to gather information on cartilage alterations. Such alterations are usually associated with forms of arthritis.
• These fluid samples were subsequently analyzed for matrix metalloproteinase (MMPs) activities by use of gelatin zymography, a technique used to detect and measure activity of these enzymes.
• The study also evaluated the cytotoxicity of tumor necrosis factor alpha (TNF-alpha) in these samples using L929 cells, commonly used in cytotoxicity assays.

Key Findings

• The results showed that MMP-9, both as a monomer and a dimer, were significantly increased in synovial fluids of joints with severe cartilage alterations, suggesting higher MMP-9 levels could be related to more severe joint damage or ongoing active arthritis.
• In contrast, the activity of TNF-alpha was found to not correlate with the degree of joint damage, implying that TNF-alpha may not serve as a reliable biomarker for arthritis in horses.
• The researchers concluded that the concentration of MMP-9 (monomer and dimer) in the synovial fluid might aid in determining the extent of cartilage alteration in horses, potentially offering a marker for early detection of osteoarthritis.